Oaktree Specialty Lending Corp. 10-Q Summary
Business Context and Reporting Period
Company: Oaktree Specialty Lending Corp. (OCSL)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2019
Business Overview: OCSL is a closed-end, externally managed Business Development Company (BDC) and Regulated Investment Company (RIC). It provides customized credit solutions, including first and second lien loans, mezzanine loans, and preferred equity, primarily to middle-market companies. The company is managed by Oaktree Capital Management, L.P.
Key Financial Metrics
| Metric | Three Months Ended June 30, 2019 | Nine Months Ended June 30, 2019 |
|---|---|---|
| Total Investment Income | $36.7 million | $113.2 million |
| Net Investment Income | $16.6 million | $51.6 million |
| Net Realized Gains (Losses) | $(19.8) million | $23.3 million |
| Net Unrealized Appreciation (Depreciation) | $23.4 million | $37.9 million |
| Net Increase in Net Assets from Operations | $20.0 million | $112.2 million |
| Earnings Per Share (Basic & Diluted) | $0.14 | $0.80 |
| Net Asset Value (NAV) Per Share | $6.60 | $6.60 |
| Total Assets | $1.485 billion | $1.485 billion |
| Total Liabilities | $555.0 million | $555.0 million |
| Net Assets | $930.1 million | $930.1 million |
| Cash and Cash Equivalents | $5.6 million | $5.6 million |
| Debt Outstanding (Credit Facility + Notes) | $528.3 million | $528.3 million |
Material Changes vs. Prior Period
- Investment Income Growth: Total investment income increased by 15.1% ($4.8 million) for the quarter and 12.6% ($12.7 million) for the nine-month period compared to the prior year. This was driven primarily by higher interest income due to increased LIBOR rates, higher average investment levels, and OID accretion, partially offset by lower fee and dividend income.
- Expense Increases: Net expenses increased by 15.2% ($2.6 million) for the quarter and 7.1% ($4.1 million) for the nine-month period. The increase was primarily due to higher incentive fees (both income and capital gains accruals), partially offset by lower interest expense and professional fees.
- Realized Gains/Losses: The company recorded net realized losses of $19.8 million for the quarter, primarily due to the exit of Advanced Pain Management. For the nine months, the company recorded net realized gains of $23.3 million, driven by exits of Maverick Healthcare, BeyondTrust, and YETI Holdings, offset by the Advanced Pain Management loss.
- Debt Repayment: The company fully repaid its $228.8 million 2019 Notes in March 2019. Consequently, unsecured notes payable decreased significantly from $386.5 million at September 30, 2018, to $158.4 million at June 30, 2019.
- Portfolio Composition: As of June 30, 2019, 88.5% of the debt portfolio bore floating interest rates. The portfolio consisted of 79.7% senior secured debt and 13.6% subordinated notes.
Guidance, Outlook, and Risks
- Asset Coverage: Effective June 29, 2019, stockholders approved the application of reduced asset coverage requirements (150% instead of 200%), allowing the company to incur up to $2 of debt for every $1 of equity. As of June 30, 2019, the asset coverage ratio was 270.4%.
- Portfolio Strategy: Management intends to continue rotating out of non-core investments (approximately $273 million remaining as of June 30, 2019) and repositioning the portfolio into core investments aligned with Oaktree's credit approach. The target mix is 40-60% first lien loans and 35-55% second lien loans.
- LIBOR Transition: The company faces uncertainty regarding the phase-out of LIBOR by 2021. It may need to renegotiate credit agreements with portfolio companies and its own credit facility (ING Facility) to transition to alternative reference rates like SOFR.
- Brookfield Transaction: Oaktree Capital Group (OCG) entered into a merger agreement with Brookfield Asset Management. While management expects to continue operating independently, the transaction is subject to closing conditions and regulatory approvals.
- Non-Accrual Status: As of June 30, 2019, five investments were on cash or PIK non-accrual status, representing 9.56% of the debt portfolio at cost. Notable non-accrual investments include Refac Optical Group and Dominion Diagnostics.
- Distributions: The Board declared a quarterly distribution of $0.095 per share on August 2, 2019, payable September 30, 2019.
Key Facts for Investor Verification
- Debt Maturity Profile: Verify the maturity dates of the remaining unsecured notes (2024 Notes due Oct 2024; 2028 Notes due Apr 2028) and the ING Facility (maturity extended to Feb 2024).
- Non-Accrual Investments: Review the specific status and potential recovery values of the five investments on non-accrual status, particularly Refac Optical Group and Dominion Diagnostics, which have past due payments.
- Fee Waivers: Note the $9.9 million cumulative potential fee waiver accrued as of June 30, 2019, related to the transition from the former adviser. The actual amount waived may differ upon the conclusion of the two-year contractual period.
- Capital Gains Incentive Fee: Verify the accrual of the capital gains incentive fee ($10.6 million for the nine months), which is based on a theoretical "liquidation basis" and may not be payable in cash if unrealized gains are not realized.
- Unfunded Commitments: Confirm the $79.5 million in unfunded commitments, primarily debt financing to portfolio companies, which represents off-balance sheet risk.